Australian Government: Australian Institute of Health and Welfare METeOR Home Page

Cancer treatment—systemic therapy agent name (primary cancer), antineoplastic drug code (Self-Instructional Manual for Tumour Registrars Book 8 3rd edn) X[X(39)]

Identifying and definitional attributes

Metadata item type:Help on this termData Element
Short name:Help on this termSystemic therapy agent name
METeOR identifier:Help on this term288446
Registration status:Help on this termHealth, Superseded 07/12/2011
Definition:Help on this termThe chemotherapeutic agent or anti-cancer drug used for treatment of the primary cancer, as represented by a code.
Data Element Concept:Cancer treatment—systemic therapy agent name (primary cancer)

Value domain attributes

Representational attributes

Classification scheme:Self-Instructional Manual for Tumour Registrars Book 8 Antineoplastic Drugs, 3rd edition
Representation class:Help on this termCode
Data type:Help on this termString
Format:Help on this termX[X(39)]
Maximum character length:Help on this term40

Data element attributes

Collection and usage attributes

Guide for use:Help on this term

The purpose of collecting specific treatment information is to account for all treatment types, which may assist in evaluation of effectiveness of different treatment patterns. The actual agents used will sometimes be of interest.

Systemic therapy often involves treatment with a combination of agents. These may be known by acronyms but since details of drugs and acronyms may vary it is recommended that each agent be recorded separately.

Oral chemotherapy normally given on an outpatient basis should also be included.

New codes and names will need to be added as new agents become available for clinical use.

Hormone therapy agents and immunotherapy agents should be recorded under this data element.

Collection methods:Help on this term

The full name of the agent(s) should be recorded if the coding manual is not available.

Comments:Help on this term

Collecting dates for systemic therapy will allow evaluation of treatments delivered and of time intervals from diagnosis to treatment, from treatment to recurrence and from treatment to death.

Source and reference attributes

Origin:Help on this term

National Cancer Institute Surveillance, Epidemiology and End Results (SEER) Program

Reference documents:Help on this term

Surveillance, Epidemiology and End Results (SEER) Program Self-instructional manual for tumour registrars: Book 8 - Antineoplastic drugs 3rd Edition National Cancer Institute.

Relational attributes

Related metadata references:Help on this term

Has been superseded by Cancer treatment—systemic therapy agent or protocol, text X[X(149)] Health, Superseded 08/05/2014

Supersedes Systemic therapy agent name, version 1, DE, NHDD, NHIMG, Superseded 01/03/2005.pdf (15.5 KB)

Implementation in Data Set Specifications:Help on this term
All attributes +

Cancer (clinical) DSS Health, Superseded 07/12/2005

DSS specific attributes +

Cancer (clinical) DSS Health, Superseded 06/03/2009

DSS specific attributes +

Cancer (clinical) DSS Health, Superseded 22/12/2009

DSS specific attributes +

Cancer (clinical) DSS Health, Superseded 07/12/2011

DSS specific attributes +
My items Help on this term
Download Help on this term